您的当前位置:首页 > 行业数据 > Paxlovid销售额资料来源:辉瑞官网,国家药品监督管理局,FDA,国盛证券研究所
图片属性
图片格式:PNG 图片大小:493KB 图片尺寸:3912*1010
同报告图片
 / 4
Paxlovid销售额资料来源:辉瑞官网,国家药品监督管理局,FDA,国盛证券研究所_第1页
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
Paxlovid销售额资料来源:辉瑞官网,国家药品监督管理局,FDA,国盛证券研究所_第2页
Paxlovid销售额资料来源:辉瑞官网,国家药品监督管理局,FDA,国盛证券研究所_第3页
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
Paxlovid销售额资料来源:辉瑞官网,国家药品监督管理局,FDA,国盛证券研究所_第4页
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
Paxlovid销售额资料来源:辉瑞官网,国家药品监督管理局,FDA,国盛证券研究所_第5页
所属报告: CDMO行业专题:礼来新药Orforglipron有望拉动小分子核心公司下一波提速-250523(20页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠